Gefitinib is effective for pathological fracture of metastatic non-small cell lung cancer

Abstract

We present a 67-year-old woman with advanced-stage lung adenocarcinoma (T2N3M1, Stage IV). Palliative surgery with an intramedullary nail was performed for the sudden onset of a pathological fracture of the right proximal femur. Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, administration without radiotherapy for 3 months led to… (More)
DOI: 10.1007/s00590-008-0406-6

Topics

3 Figures and Tables

Cite this paper

@article{Hoshi2008GefitinibIE, title={Gefitinib is effective for pathological fracture of metastatic non-small cell lung cancer}, author={Manabu Hoshi and Masatsugu Takami and Makoto Ieguchi and Kunio Takaoka}, journal={European Journal of Orthopaedic Surgery & Traumatology}, year={2008}, volume={19}, pages={181-185} }